Prognostic Impact of Direct (131)I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study

Background: Patients treated for intermediate- or high-risk differentiated thyroid carcinoma (DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body scan (DWBS) and if positive, (131)I treatment. This approach can lead to a delay in treatment and increased costs. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo, José F., Vázquez-Romo, Rafael, Ramírez-Ortega, Margarita C., Carrillo, Liliana C., Gómez-Argumosa, Edgar, Oñate-Ocaña, Luis F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828732/
https://www.ncbi.nlm.nih.gov/pubmed/31736875
http://dx.doi.org/10.3389/fendo.2019.00737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828732/
https://www.ncbi.nlm.nih.gov/pubmed/31736875
http://dx.doi.org/10.3389/fendo.2019.00737

Ejemplares similares